CVS Insider Buy: Prem Shah Spends $2 Million on CVS Stock at $83.89

As seen on the 24/7 Wall St. homepage on November 6, 2026.

Bought CVS HEALTH Corp $2M23,855 shares @ $83.895

Prem Shah just put roughly $2 million of his own money into CVS stock, lifting his stake by about 27% days after the breakup plan sent shares down. Open-market buying by an operating executive is the rarest insider signal there is, and it lands while the FTC probe into Caremark is still open.

Continue ReadingShow less

Prem S. Shah purchased 23,855 shares of CVS Health on November 6, 2026, at $83.895 per share, spending just over $2 million of his own money. The transaction lifted his total stake by roughly 27%, a meaningful concentration of personal wealth into a single position.

Open-market purchases by operating executives are the rarest category of insider signal because, unlike option exercises or scheduled trading plans, they require the insider to write a check at the current market price with no guaranteed upside. The filing does not indicate this trade was made under a pre-scheduled plan.

Sponsored

The buy came days after a breakup plan sent CVS shares lower, with Shah adding at a depressed price. That kind of conviction purchase is what institutional investors typically flag as a high-attention insider event.

The trade also lands while a Federal Trade Commission probe into the company's Caremark pharmacy benefit management unit remains open. Shah's willingness to add roughly $2 million in personal exposure while that regulatory overhang persists makes the purchase harder to dismiss as routine portfolio management.

Mentioned: CVS